Yahoo Web Search

Search results

  1. 5 days ago · The NUS Office of Student Affairs (OSA) seizes every opportunity to supports the NUS student community through student services, residential admission, clubs, leaders’ training, community engagement, integration and service learning, health and wellness, as well as disability support.

  2. 1 day ago · Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep.These episodes are termed "apneas" with complete or near-complete cessation of breathing, or "hypopneas" when the reduction in breathing is partial.

  3. 4 days ago · Snapshot. A 56-year-old man presents to your office for excessive fatigue. He complains of falling asleep all the time at work, which is “very distressing" as it has been affecting his work. He denies sudden loss of muscle tone or hallucinations before or after falling asleep. His wife reports that he snores at night.

  4. 4 days ago · For people with moderate-to-severe obstructive sleep apnea (OSA) and obesity, treatment with Mounjaro (tirzepatide; Lilly, Indianapolis, IN) was associated with reduced apnea-hypopnea index (AHI), body weight, hypoxic burden, high-sensitivity C-reactive protein (hsCRP) concentration, and systolic blood pressure, as well as improved sleep-related patient-reported outcomes.

  5. 1 day ago · This group of patients has increased risk of OSA, possibly due to AR obstruction inhibiting nasal receptors and increasing airflow resistance. The authors recommend that, given its high prevalence and morbidity, patients with AR with moderate-to-severe sleep impairment should be considered for sleep disorder evaluation.

  6. 4 days ago · Orthodontic treatment for OSA can be helpful and effective. However, this may be done only after referral to the appropriate physician specialist, as part of a multi-disciplinary team, with consideration of the likely effectiveness of treatment, and after all likely and potential negative consequences have been considered and thoroughly discussed with the patient.

  7. 1 day ago · Type 2 diabetes drug tirzepatide has been shown to be effective in treating moderate to severe sleep apnoea in a worldwide clinical trial. US researchers showed that tirzepatide (Mounjaro) — a GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist (RA) — can significantly lowers breathing interruptions during sleep, a key indicator of obstructive sleep apnoea (OSA) severity.

  8. 4 days ago · The SURMOUNT-OSA trials are pivotal for several reasons. First, they address a critical gap in the treatment of OSA by introducing a pharmacologic option that targets the root cause—excess adiposity. Second, the trials comprehensively evaluate the multifaceted benefits of tirzepatide, beyond its weight reduction properties.

  9. 3 days ago · Discover SUNOSI® (solriamfetol), a prescription treatment to improve wakefulness for excessive daytime sleepiness (EDS) due to obstructive sleep apnea (OSA) or narcolepsy. See safety info about use with MAOIs.

  10. 4 days ago · Summary: Nyxoah has submitted the fourth and final module of its Premarket Approval (PMA) application to the FDA for its Genio neurostimulator, designed to treat obstructive sleep apnea (OSA). The Genio system, which is fully-body MRI-compatible and powered by a wearable, demonstrated significant efficacy in the DREAM US pivotal study.

  1. People also search for